Commentary: After Disastrous September and 2022 Midterms Looming, Biden May Have Lost His Mandate to Govern

Following a catastrophic U.S. military withdrawal from Afghanistan, the highest inflation since 2008,pushing unpopular COVID vaccine mandates, rationing COVID treatments to red states and finally, watching his domestic legislative agenda falter in Congress, President Joe Biden is already upside down on his job approval ratings, according to the latest average of polls compiled by RealClearPolitics.com.

Reuters/Ipsos on Sept. 29-30 had Biden’s approval at 46 percent and disapproval at 50 percent.

Read More

Florida Governor DeSantis Bypasses Biden Administration, Acquires Monoclonal Antibodies Directly from GlaxoSmithKline

Florida Governor Ron DeSantis announced on Thursday that the state of Florida purchased thousands of monoclonal antibody treatments directly from GlaxoSmithKline, a producer of the treatment.

The move by DeSantis bypasses a restriction placed by President Joe Biden’s administration, allowing the federal government to dictate allocations to each state and leave it to state leaders to ration it out among locations.

Read More

State Representative Scott Cepicky Weighs in on Tennessee Department of Health Commissioners Monoclonal Antibody Guidelines

Wednesday morning on the Tennessee Star Report, host Michael Patrick Leahy welcomed Maury County Tennessee State Representative Scott Cepicky to the newsmakers line to discuss monoclonal antibody guidelines, calling a special session, and circumventing the federal government.

Read More

Two Big Pharmaceutical Companies Sell Monoclonal Antibodies to Federal Government Only, Refuse to Sell to Hospitals or States

Officials with two pharmaceutical companies who produce monoclonal antibody treatments said Wednesday that the U.S. government distributes the currently-available supply of those treatments and that those companies may not sell them to hospitals or state governments. A spokesman for the New York state-based Regeneron, who identified himself only as Alex, said the U.S. government owns the currently available supply of REGEN-COV, which is the company’s monoclonal antibody treatment. The U.S. government allocates that product to state governments.

Read More